We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

69 hedge funds and large institutions have $303M invested in Cogent Biosciences in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 11

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

0% more funds holding

Funds holding: 69 → 69 (0)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

18% less capital invested

Capital invested by funds: $370M → $303M (-$67M)

20.46% less ownership

Funds ownership: 113.14% → 92.68% (-20%)

Holders
69
Holders Change
–
Holders Change %
0%
% of All Funds
1.21%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
18
Increased
27
Reduced
11
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$12.3M
2
Millennium Management
Millennium Management
New York
+$6.93M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$5.34M
4
CC
Commodore Capital
New York
+$4.9M
5
GTC
Ghost Tree Capital
New York
+$4.81M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$8.32M
2
O
OrbiMed
New York
-$7.36M
3
CCM
Consonance Capital Management
New York
-$6.85M
4
ACM
Altium Capital Management
New York
-$4.86M
5
LGM
Logos Global Management
California
-$4.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$221K +$115K +11,972 +91%
State Street
52
State Street
Massachusetts
$177K – – –
WC
53
Wexford Capital
Florida
$176K – – –
EGM
54
Engineers Gate Manager
New York
$163K +$178K +18,524 New
DC
55
Diametric Capital
Massachusetts
$121K +$132K +13,728 New
CGIM
56
Cannon Global Investment Management
Florida
$121K +$133K +13,800 New
BFM
57
Boothbay Fund Management
New York
$98K +$107K +11,109 New
LPL Financial
58
LPL Financial
California
$97K +$106K +11,000 New
Squarepoint
59
Squarepoint
New York
$90K -$19.1K -1,982 -16%
V
60
Veritable
Delaware
$88K +$96.7K +10,041 New
MS
61
Maven Securities
Jersey
$31K +$33.9K +3,519 New
GRP
62
Global Retirement Partners
California
$16K +$1.17K +121 +7%
Acadian Asset Management
63
Acadian Asset Management
Massachusetts
$5K +$5.87K +610 New
Bessemer Group
64
Bessemer Group
New Jersey
$2K +$2.71K +282 New
Bank Julius Baer & Co
65
Bank Julius Baer & Co
Switzerland
$1K -$221 -23 -26%
Wells Fargo
66
Wells Fargo
California
$1K -$10 -1 -0.6%
NFSG
67
Newbridge Financial Services Group
Florida
$1K +$1.18K +122 New
O
68
OrbiMed
New York
– -$7.36M -655,000 Closed
CCM
69
Consonance Capital Management
New York
– -$6.85M -610,000 Closed
SB
70
Samsara BioCapital
California
– -$6.61K -588,961 Closed
ACM
71
Altium Capital Management
New York
– -$4.86M -432,563 Closed
Renaissance Technologies
72
Renaissance Technologies
New York
– -$364K -32,445 Closed
HA
73
HC Advisors
Georgia
– -$353K -31,395 Closed
Two Sigma Advisers
74
Two Sigma Advisers
New York
– -$341K -30,347 Closed
MFS
75
Mirabella Financial Services
United Kingdom
– -$325K -28,920 Closed
1 2
3
4

COGT Hedge Fund Activity: Q1 2021 in Review

69 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2021, worth a combined $303M — down 18% from $370M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new COGT positions and 17 closed out — a net gain of 1 holder — while 27 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $12.3M. The largest seller was Morgan Stanley, cutting an estimated $8.32M.

  • 69 institutional investors held Cogent Biosciences (COGT) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $303M of Cogent Biosciences stock for Q1 2021, down 18% quarter-over-quarter.
  • 18 funds opened new Cogent Biosciences positions in Q1 2021 and 17 closed out, a net change of +1 holder.
  • The largest Cogent Biosciences buyer in Q1 2021 was Vanguard Group, an estimated $12.3M added.
  • The largest Cogent Biosciences seller in Q1 2021 was Morgan Stanley, an estimated $8.32M sold.

Based on aggregated 13F filings for Q1 2021.